JCX-13-22 (June 24, 2022)
Estimated Revenue Effects Of The House Amendment To The Senate Amendment To H.R.4346, Scheduled For Consideration By The House Of Representatives On June 24, 2022 (Rules Committee Print 117-53)
The House or Representatives will consider Rules Committee Print 117-53 relating to the addition of vaccines against COVID-19 to the list of taxable vaccines. The staff of the Joint Committee on Taxation has prepared an estimate of the budgetary effect of this legislation.
The House or Representatives will consider Rules Committee Print 117-53 relating to the addition of vaccines against COVID-19 to the list of taxable vaccines. The staff of the Joint Committee on Taxation has prepared an estimate of the budgetary effect of this legislation.
Related Publications
-
JCX-35-25 (July 01, 2025)
Estimated Revenue Effects Relative To The Present Law Baseline Of The Tax Provisions In “Title VII – Finance” Of The Substitute Legislation As Passed By The Senate To Provide For Reconciliation Of The Fiscal Year 2025 Budget
view details -
JCX-34-25 (July 01, 2025)
Estimated Revenue Effects Relative To The Current Policy Baseline Of The Tax Provisions In “Title VII – Finance” Of The Substitute Legislation As Passed By The Senate To Provide For Reconciliation Of The Fiscal Year 2025 Budget
view details -
JCX-33-25 (July 01, 2025)
Distribution Of The Estimated Revenue Effects Of The Tax Provisions In "Title Vii - Finance" Of The Substitute Legislation Under Consideration By The Senate To Provide For Reconciliation Of The Fiscal Year 2025 Budget
view details